medline.ch Onkologie Urologische Tumoren

	Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives. Discov Oncol Giunta EF, Schepisi G, Bleve S, Serra R, Brighi N, Torresan I, Tassinari E, Zanuccoli S, Lolli C. PMID: 41689691 [PubMed - as supplied by publisher]
	Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25. Cancer Immunol Immunother Roviello G, Gambale E, De Gennaro Aquino I, Maruzzo M, Messina C, Vascotto IA, Rossi V, Bimbatti D, Erbetta E, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Catalano M, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Pillozzi S, Antonuzzo L. PMID: 41689638 [PubMed - indexed for MEDLINE]
	Pharmacokinetics and Dosimetry of [(68)Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study. Cancer Biother Radiopharm Fan W, Li Y, Shi H, Guo J, Huang R, Dong Q, Yang Z, Yang Y, Wang X, Gu D, Ye D, Wang F, Wang J, Xu D, Jiang Z, Li H, Li J, Li R, Huo L, Ji Z. PMID: 41689461 [PubMed - as supplied by publisher]
	The Modified Frailty Index-5 as a Predictor of Postoperative Complications Following Radical Cystectomy. J Coll Physicians Surg Pak Dincer E, Ozkaptan O, Canakci C, Ipek OM, Coskun A, Can U. PMID: 41689329 [PubMed - indexed for MEDLINE]
	Magnetic resonance-guided simultaneous multi-foâ€‹cal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study. Radiat Oncol Sun M, Qin SR, Wei R, Tian Y, Yan LL, Xia WL, Liu ZQ, Fu Q, Song YW, Fang H, Jing H, Wang SL, Li YX, Xing NZ, Lu NN. PMID: 41689033 [PubMed - as supplied by publisher]
	Contemporary Role for Blue Light Cystoscopy Across the Bladder Cancer Disease Spectrum. Curr Urol Rep Wan E, Wade C, Sathe A, Ferguson JE 3rd, Peyton CC. PMID: 41688839 [PubMed - in process]
	The Relationship Between Prostate Cancer Treatments and Changes to Musculature: A Systematic Review. Clin Oncol (R Coll Radiol) Partridge L, Vickers A, McSweeney D, Shortall J, McWilliam A. PMID: 41688299 [PubMed - as supplied by publisher]
	Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life Study. Clin Genitourin Cancer Støyten M, Knutsen T, Thune I, Stikbakke E, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Schirmer H, Haugnes HS. PMID: 41688223 [PubMed - as supplied by publisher]
	Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference Study. Urology Smith AB, Gore JL, Chisolm S, Squires P, Li H, Dave H, Mansfield C, Vass C. PMID: 41687978 [PubMed - as supplied by publisher]
	Local treatment for metastatic and primary sites in metastatic renal cell carcinoma in the combination immunotherapy era: a narrative review. Int J Clin Oncol Abe J, Murashima T, Kojima S, Ueno T, Takei A, Nakai N, Akioka T, Kamoto T, Sawada A. PMID: 41686385 [PubMed - as supplied by publisher]
	Intensive nursing interventions for post-treatment anxiety and depression in bladder cancer: A systematic review and meta-analysis. Support Care Cancer Huang X, Chen R, Guo Z, Song C, Li X. PMID: 41686342 [PubMed - indexed for MEDLINE]
	Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging Donswijk ML, Ettema RH, Wondergem M, Cheung Z, van der Poel HG, Oprea-Lager DE, Vis AN. PMID: 41686217 [PubMed - as supplied by publisher]
	Transcriptome and single-cell RNA sequencing analysis with 101 machine learning combinations and experimental verification reveals the mechanism of action of mannose metabolism in bladder cancer. Front Immunol Li A, Zhao K, Wang T, Shi G. PMID: 41685329 [PubMed - indexed for MEDLINE]
	Prognostic gene screening and experimental validation in renal clear cell carcinoma based on spatial transcriptomics and single-cell sequencing. Front Immunol Fu C, Sun L, Zhou T, Bi Y. PMID: 41685311 [PubMed - indexed for MEDLINE]
	Prostate Cancer-Associated Fibroblasts: A Review on CAF Functions, Heterogeneity, Resistance Mechanisms, and Future in a Chip. Int J Mol Sci Lupsa N, Heninger E, Ding AB, Sanchez De Diego C, Vietor K, Reese SR, LeBeau AM, Kosoff D, Beebe DJ, Kerr SC, Lang JM. PMID: 41684004 [PubMed - indexed for MEDLINE]
	Vitamin D-Related Information Exposure, Attitudes, and Practices Among Prostate and Breast Cancer Survivors in Poland: Implications for Patient-Physician Communication. Nutrients Miko, Kaczmarczyk K, Miko. PMID: 41683252 [PubMed - indexed for MEDLINE]
	Intersection of Precision Nutrition and Bladder Cancer: A Narrative State-of-the-Art Review of Potential Applications and Challenges. J Clin Med Koçak T, Özbek YD, Bodur M, Ye, A. PMID: 41682926 [PubMed]
	Prognostic Value of the Lung Immune Prognostic Index (LIPI) in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study. J Clin Med Ünlü B, Demir H, Davarc, Culha Y, Baykara M. PMID: 41682869 [PubMed]
	Perioperative Immune-Checkpoint Inhibition in Renal Cell Carcinoma: Lessons Learned and Future Directions. Cancers (Basel) Adika A, Zibelman M. PMID: 41681998 [PubMed]
	SLPI in Prostate Cancer. Cancers (Basel) Rosini D, Cosi I, De Iaco P, Sebastianelli A, Di Stefano G, Serni S, Nesi G, Notaro R, De Angioletti M. PMID: 41681959 [PubMed]

Artikel 1 - 20 / 175989

Seite 1 von 8800

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung